Janus Henderson Group PLC Dbv Technologies S.A. Transaction History

Janus Henderson Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$5.81 - $9.37 $3.98 Million - $6.42 Million	-684,729 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$5.75 - $21.85 $8.74 Million - $33.2 Million	-1,520,605 Reduced 68.95%	684,729 $4.4 Million
Q3 2018 Nov 09, 2018	SELL	$16.81 - $24.58 $13.7 Million - $20.1 Million	-817,554 Reduced 27.05%	2,205,334 $49.5 Million
Q2 2018 Aug 10, 2018	BUY	$18.6 - $24.94 $3.16 Million - $4.23 Million	169,765 Added 5.95%	3,022,888 $58.3 Million
Q1 2018 May 14, 2018	BUY	$20.86 - $26.6 $2.02 Million - $2.58 Million	97,067 Added 3.52%	2,853,123 $65.8 Million
Q4 2017 Feb 09, 2018	SELL	$20.9 - $49.36 $872,219 - $2.06 Million	-41,733 Reduced 1.49%	2,756,056 $67.8 Million
Q3 2017 Nov 14, 2017	BUY	$39.62 - $46.17 $10.2 Million - $11.9 Million	257,210 Added 10.12%	2,797,789 $0
Q2 2017 Aug 17, 2017	BUY	N/A	2,540,579	2,540,579 $90.7 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $95.8M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.